Bergstrom Donald A 4
4 · Relay Therapeutics, Inc. · Filed Jul 8, 2026
Research Summary
AI-generated summary of this filing
Relay Therapeutics (RLAY) President R&D Donald Bergstrom Sells Shares
What Happened Donald A. Bergstrom, President of Research & Development at Relay Therapeutics (RLAY), sold 8,660 shares of RLAY in an open-market sale on July 6, 2026. The weighted average sale price reported was $18.71 per share, for aggregate proceeds of $162,029. This was a sale (code S), not a purchase or award.
Key Details
- Transaction date: July 6, 2026; Form 4 filed July 8, 2026 (timely filing).
- Price: weighted average $18.71; individual trade prices ranged $18.45–$19.36 (transaction executed in multiple trades).
- Amount: 8,660 shares sold; total proceeds $162,029.
- Ownership note: filing indicates holdings include 15,037 shares underlying restricted stock units (RSUs).
- Footnotes: sale was made pursuant to a Rule 10b5-1 trading plan adopted Oct 30, 2025; the filer can provide per-trade breakdown on request.
Context This sale was carried out under a pre-established 10b5-1 plan, which is commonly used to schedule insider sales in advance and can reflect routine liquidity needs rather than a change in outlook. Sales are generally less informative than purchases about insider conviction; no exercise of options or gifts were reported in this filing.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-07-06$18.71/sh−8,660$162,029→ 409,897 total
Footnotes (3)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $18.45 to $19.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 15,037 shares underlying restricted stock units.